Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2002

View Archived Issues

New anti-H. pylori agents identified by American researchers

Dual DHFR/TS inhibitors with potential in cancer and opportunistic infections

Novel VEGFR inhibitors prepared and tested at Taisho

HE-2500, HE-2200 prove effective in animal models of multiple sclerosis

Immunomodulatory effects described for simvastatin in PBMCs from MS patients

New product for cancer heading for clinical testing at ProMetic

First nucleotide analogue for HBV approved by FDA

Worldwide development and marketing agreement for epothilone D in cancer

Forest withdraws NDA to amend and refile later this year

First Rigel compound enters clinical testing for allergic rhinitis

Potential new antidepressant presented by Faes in Toledo

Pharmacokinetics of components of AVP-923 examined in poor and extensive metabolizers

Candidate malaria vaccine emerges from research by Australian and U.S. scientists

Antibacterial quinolones in early development at Pharmacia

Kaken identifies VLA-4 antagonists

Fujisawa and Pharmagenesis collaborate on triptolide derivatives

Benefits of tiotropium in COPD become evident upon withdrawal

FDA issues approvable letter for Metvix

Trospium meets endpoints in phase III overactive bladder trial

Tarceva receives second fast track designation

Phase I cleared for Islet Neogenesis Therapy

Safety data for omalizumab reported at the 2002 ERS congress

Clopidogrel approved in E.U. for patients with acute coronary syndrome

Biotica expands macrolide antiinfective research collaboration with Pfizer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...